(NASDAQ:JSPR), REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper or the Company), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma, today […]

Argo Corporation Reports Third Quarter 2025 Financial Results GlobeNewswire December 01, 2025 TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Argo Corporation (TSXV: ARGH), (OTCQX: ARGHF) (“Argo” or the “Company“), a leader in next-generation transit solutions, announced its financial results for the quarter ended September 30, 2025 (“Q3 2025“). All figures are in Canadian dollars unless

Precision Aerospace & Defense Group, Inc. to Combine with FACT II Acquisition Corp. to Become Publicly Listed Company GlobeNewswire December 01, 2025 Highlights Precision Aerospace & Defense Group, Inc. (“PAD”) to merge with FACT II Acquisition Corp. (NASDAQ: FACT) (“FACT”), creating a Nasdaq-listed holistic solutions provider in the aerospace, defense and space industries. PAD's strong

Rivalry Reports Q3 2025 Results Highlighting Continued Revenue Growth and Structural Efficiency Operating expenses reduced 58% year-over-year and net loss improved 67% as Rivalry posts third consecutive quarter of revenue growth and completes debt restructure and recapitalization to enter 2026 on a strengthened foundation GlobeNewswire December 01, 2025 TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) —

Capital Power provides notice of Preferred Shares (Series 1) conversion privilege and dividend rate notice GlobeNewswire December 01, 2025 EDMONTON, Alberta, Dec. 01, 2025 (GLOBE NEWSWIRE) — Capital Power Corporation (“Capital Power”) (TSX: CPX) announced today that it has notified registered shareholders of its Cumulative Rate Reset Preference Shares, Series 1 (the “Series 1 Shares”)

Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference GlobeNewswire December 01, 2025 PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the Citi

Receipt of Delinquency Notification from Nasdaq GlobeNewswire December 01, 2025 Singapore, Dec. 01, 2025 (GLOBE NEWSWIRE) — Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that it has received notification from Nasdaq that the Company's annual report on Form 20-F for the fiscal year ended June 30, 2025 was incomplete and that the

Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation Webinar to be held Tuesday, December 2nd, at 8:00 am ET GlobeNewswire December 01, 2025 REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper

(TSX-V:BLM),(Other OTC:BLMWF), THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. THE SHELF PROSPECTUS SUPPLEMENT, THE CORRESPONDING BASE SHELF PROSPECTUS AND ANY AMENDMENT TO THE DOCUMENTS ARE ACCESSIBLE THROUGH SEDAR+ OR WILL BE ACCESSIBLE THROUGH SEDAR+ WITHIN

BluMetric Announces Acquisition of DS Consultants and $15 Million Brokered Offering GlobeNewswire December 01, 2025 THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. THE SHELF PROSPECTUS SUPPLEMENT, THE CORRESPONDING BASE SHELF PROSPECTUS AND ANY AMENDMENT TO